Related Experiment Video
Updated: Jun 20, 2025

MicroRNA In situ Hybridization for Formalin Fixed Kidney Tissues
Published on: November 30, 2013
ADAMTS16 Suppression by MicroRNA-25 Leads to Oncogenic Properties in Renal Cell Carcinoma
Jian Huang1, Zhe Tang1, Guangjun Zhong1
1Department of Urology, The First Affiliated Hospital of Yangtze University, Jingzhou, 434000, Hubei Province, P.R.China.
Introduction:
Increasing evidence indicates that microRNAs (miRNAs) play a crucial role in modulating tumor growth. This study is centered on investigating the contribution of miR-25 to the progression of Renal Cell Carcinoma (RCC).
Methods:
The investigators examined the expression levels of miR-25 and ADAMTS16 in RCC samples and cell lines. The association between miR-25 and ADAMTS16 was validated via a luciferase reporter assay. Cell viability, apoptosis, migration, and invasion were evaluated utilizing CCK-8 and flow cytometry techniques, while the expression levels of ADAMTS16, β-catenin, GSK-3β, and p-GSK-3β were assessed through western blot analysis.
Results:
The investigation revealed elevated expression levels of miR-25 in RCC tissues. Subsequently, ADAMTS16 was identified as a target of miR-25. Increased miR-25 levels were associated with decreased expression of ADAMTS16, resulting in enhanced cell viability and diminished apoptosis. Conversely, inhibition of miR-25 led to decreased cell viability, proliferation, and migration. Additionally, the researchers observed that miR-25 triggered the phosphorylation of GSK-3β and β-catenin while leaving the total GSK-3β level unaffected.
Conclusion:
This study suggests that miR-25 regulates the expression of ADAMTS16 through the Wnt/β-catenin signaling pathway, providing new insights into the cause and potential treatment of RCC.
Insights
MicroRNA-25 (miR-25) promotes Renal Cell Carcinoma (RCC) progression by downregulating ADAMTS16 and activating the Wnt/β-catenin pathway. Inhibiting miR-25 reduces RCC cell viability and migration, offering potential therapeutic targets.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- MicroRNAs (miRNAs) are key regulators of tumor growth.
- Renal Cell Carcinoma (RCC) progression is influenced by various molecular mechanisms.
- The specific role of miR-25 in RCC requires further elucidation.
Purpose of the Study:
- To investigate the contribution of miR-25 to Renal Cell Carcinoma (RCC) progression.
- To identify the molecular targets and pathways regulated by miR-25 in RCC.
- To explore the potential of targeting miR-25 for RCC treatment.
Main Methods:
- Examined miR-25 and ADAMTS16 expression in RCC tissues and cell lines.
- Validated miR-25 targeting of ADAMTS16 using luciferase reporter assays.
- Assessed cell viability, apoptosis, migration, and invasion via CCK-8 and flow cytometry.
- Analyzed protein expression of ADAMTS16, β-catenin, GSK-3β, and p-GSK-3β using western blot.
Main Results:
- miR-25 expression was significantly elevated in RCC tissues.
- ADAMTS16 was identified as a direct target of miR-25, with higher miR-25 correlating to lower ADAMTS16 levels.
- Overexpression of miR-25 enhanced RCC cell viability and migration while suppressing apoptosis.
- miR-25 promoted Wnt/β-catenin pathway activation by phosphorylating GSK-3β and β-catenin.
Conclusions:
- miR-25 promotes RCC progression by downregulating ADAMTS16.
- The Wnt/β-catenin signaling pathway is implicated in miR-25-mediated RCC development.
- miR-25 represents a potential therapeutic target for Renal Cell Carcinoma.
Related Concept Videos
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Induced Pluripotent Stem Cells
Somatic...
PI3K/mTOR/AKT Signaling Pathway

